(Q54582715)

English

Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy

scientific article published on October 15, 1994

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/7522948

Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy (English)

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

1 reference

based on heuristic

inferred from title

author name string

M. Venturini

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522948

16 May 2024

G. Melioli

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522948

16 May 2024

E. Balleari

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522948

16 May 2024

W. Pasquetti

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522948

16 May 2024

C. Bason

7

0000-0002-9421-3212

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522948

16 May 2024

R. Ghio

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522948

16 May 2024

P. Bruzzi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522948

16 May 2024

R. Rosso

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522948

16 May 2024

language of work or name

0 references

publication date

1 October 1994

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/7522948

15 October 1994

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7522948

16 May 2024

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/7522948

74

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/7522948

8

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/7522948

2300-2306

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/7522948

A comparison of peripheral blood stem cell mobilisation after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819941015%2974%3A8%3C2300%3A%3AAID-CNCR2820740814%3E3.0.CO%3B2-K

21 January 2018

Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819941015%2974%3A8%3C2300%3A%3AAID-CNCR2820740814%3E3.0.CO%3B2-K

21 January 2018

High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer

2

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial

3

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

7

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man.

8

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF.

9

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer

12

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trial.

14

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

15

77

457

author name string

Patrone

publication date

1992

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial

18

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy

20

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

Sequential High-Dose Combination Chemotherapy With Granulocyte Colony-Stimulating Factor and Peripheral Blood Progenitor Cells in Patients With Solid Tumors: Intensification Limited by Nonhematologic Toxic Effects

21

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

Biology of Hodgkin's disease

25

1 reference

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19941015)74:8%3C2300::AID-CNCR2820740814%3E3.0.CO;2-K

16 May 2024

Identifiers

10.1002/1097-0142(19941015)74:8<2300::AID-CNCR2820740814>3.0.CO;2-K

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/7522948

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/7522948

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54582715&oldid=2155652601"